Sponsor:
St. Joseph's Healthcare Hamilton
Code:
NCT06707519
Conditions
Lung Cancer
Circulating Tumor DNA
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Brief summary:
Conditions
Lung Cancer
Circulating Tumor DNA
Study ID
NCT06707519
Start date
Feb 1, 2023
Status verified date
Apr, 2026
Completion date
Dec 29, 2027
Anticipated
Primary completion date
Dec 29, 2027
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
210 participants
Anticipated
Primary outcome measure
Central contacts
Locations
St. Joseph's Healthcare Hamilton
Recruiting
Hamilton, Ontario, Canada, L8N 4A6
Contacts
Principal Investigator:
Yaron Shargall, MD
Sponsor
St. Joseph's Healthcare Hamilton
Last update posted
Apr 22, 2026
Last verified
Apr, 2026
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by St. Joseph's Healthcare Hamilton on 2026-04-22.